Skip to main navigation Skip to search Skip to main content

Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab

  • ODYSSEY OUTCOMES Investigators

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science